4-[2-(2-dibenzothiophen-4-ylphenyl)phenyl]-6-(9-methyl-9-phenylfluoren-2-yl)-2-phenylpyrimidine
C54H36N2S — CID 171603132
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[2-(2-dibenzothiophen-4-ylphenyl)phenyl]-6-(9-methyl-9-phenylfluoren-2-yl)-2-phenylpyrimidine
4-[2-(2-dibenzothiophen-4-ylphenyl)phenyl]-6-(9-methyl-9-phenylfluoren-2-yl)-2-phenylpyrimidine (PubChem CID 171603132) has the molecular formula C54H36N2S and a molecular weight of 744.96 g/mol. Its IUPAC name is 4-[2-(2-dibenzothiophen-4-ylphenyl)phenyl]-6-(9-methyl-9-phenylfluoren-2-yl)-2-phenylpyrimidine.
Molecular Properties
| Compound Name | 4-[2-(2-dibenzothiophen-4-ylphenyl)phenyl]-6-(9-methyl-9-phenylfluoren-2-yl)-2-phenylpyrimidine |
|---|---|
| PubChem CID | 171603132 |
| Molecular Formula | C54H36N2S |
| Molecular Weight | 744.96 g/mol |
| Exact Mass | 744.26 |
| IUPAC Name | 4-[2-(2-dibenzothiophen-4-ylphenyl)phenyl]-6-(9-methyl-9-phenylfluoren-2-yl)-2-phenylpyrimidine |
| SMILES | CC1(c2ccccc2)c2ccccc2-c2ccc(-c3cc(-c4ccccc4-c4ccccc4-c4cccc5c4sc4ccccc45)nc(-c4ccccc4)n3)cc21 |
| InChI | InChI=1S/C54H36N2S/c1-54(37-19-6-3-7-20-37)47-29-14-12-24-41(47)42-32-31-36(33-48(42)54)49-34-50(56-53(55-49)35-17-4-2-5-18-35)43-25-11-10-22-39(43)38-21-8-9-23-40(38)45-27-16-28-46-44-26-13-15-30-51(44)57-52(45)46/h2-34H,1H3 |
| InChIKey | SHYZWDJPFMNQHC-UHFFFAOYSA-N |
| XLogP | 14.51 |
| TPSA | 25.78 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 57 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 744.96 |
| LogP ≤ 5 | 14.51 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171603132 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.